AS‑OCT maps anterior chamber particles
- A new Eye review says anterior-segment OCT can turn floating anterior-chamber “cells” into measurable image markers, pushing inflammation checks beyond slit-lamp estimates. - The key detail is method variability: scan protocol, device, and particle-size threshold all change counts, but low-volume scans still tracked SUN grades well. - That matters because clinics want faster, more objective uveitis triage and postoperative monitoring without relying only on subjective chairside grading.
Anterior-segment OCT is basically a front-of-the-eye scanner. It already helps with cornea, angle, and surgical planning. What is changing now is how people use it inside the anterior chamber — not just to look at anatomy, but to count tiny bright specks that may represent inflammatory cells, pigment, or other debris. A new review in *Eye* argues that this is getting close to being a practical biomarker, but only if clinics stop treating every scan method as interchangeable. ### What are these “particles” anyway? On AS-OCT, they show up as hyper-reflective dots floating in the fluid-filled space between the cornea and iris. In uveitis workups, those dots are often used as a digital stand-in for anterior-chamber inflammation. That sounds simple, but the catch is that not every bright dot is the same thing — some are inflammatory cells, some are pigment, and some may be postoperative material or imaging noise. ### Why isn’t the slit lamp enough? (nature.com) The slit lamp is still the clinical standard, usually with SUN grading. But SUN cell grading is semiquantitative and observer-dependent — two clinicians can look at the same eye and not land on exactly the same number. OCT changes the game because it gives you a saved image, a countable signal, and in some systems an automated density metric instead of a quick visual estimate. ### What did the new review actually add? (nature.com) The review did not just say “OCT can see cells.” That part has been around for years. The useful step was comparing how different studies acquired scans, defined particles, and linked those counts to clinical inflammation grades. The main takeaway is that operator choices matter a lot — scan density, scan volume, and analysis thresholds can all shift performance — so raw counts from one protocol should not be casually compared with another. (tvst.arvojournals.org) ### Which metrics seem most useful? Most groups end up using some version of particle count or particle density within the anterior chamber. One 2022 study in angle-closure glaucoma patients created an anterior chamber particle index — particles divided by chamber area — and showed a jump from 0.78 before laser iridotomy to 7.72 immediately after, then back near baseline a week later. That is a good example of why the method is attractive: it captures change over time, not just a one-off impression. (nature.com) ### Can the software do this automatically? Increasingly, yes. AI-assisted and automated pipelines have already shown strong correlations with clinical grading. In one prospective study, automated particle count and density both tracked SUN grades, with Spearman correlations a little above 0.70. Another recent paper reported that automated counts on swept-source AS-OCT images could work on 67 eyes with uveitis involving the anterior segment. So the field is moving from “humans can annotate this” to “software can do it reproducibly.” (pmc.ncbi.nlm.nih.gov) ### What is the hard part? Specificity. A bright dot is not a pathology label. A 2025 cross-sectional study showed that larger particles — above 4 pixels, roughly above 24 microns in that setup — correlated with SUN inflammation grades, but pigment can still confuse the picture. That means AS-OCT is promising as an adjunct, not a replacement, especially in eyes with pigment dispersion, recent surgery, or mixed debris. ### Where does this matter first? (tvst.arvojournals.org) Uveitis triage is the obvious near-term use. But postoperative monitoring and glaucoma workflows matter too — especially when clinicians want a quick, noncontact, repeatable way to document whether chamber debris is rising or settling. Low-volume scan protocols may be especially practical because they preserve useful correlation without the storage and analysis burden of denser scans. ### Bottom line? (pmc.ncbi.nlm.nih.gov) AS-OCT is turning anterior-chamber particles into something closer to a lab value than a glance. But for that to matter in clinic, the field needs standard scan protocols and clearer rules for what kind of particle is actually being counted. (nature.com) (ajo.com)
